各位朋友下午好，这里是帮主郑重的收评时间。今天A股又走了个震荡行情，三大指数里创业板跌得稍多点，收盘跌了0.36%，沪指和深成指就小幅调整， 差不多是意思意思跌了一丢丢。全市场成交额1.2万亿出头，比昨天稍微缩了点量，不过个股表现挺热闹——近3000只股票飘绿，估计不少朋友看着账户又 有点小纠结。 最后跟大伙儿唠唠我这中长线的看法。现在市场就是典型的结构性行情，板块轮动快得像翻书，今天涨的明天不一定咋样。这种时候咱更得沉住气，别被短 期波动带节奏。尤其是中长线投资，得盯着那些业绩能扛、逻辑硬的方向，像科技成长里真有技术的公司，或者消费里需求慢慢回暖的领域，都值得多琢 磨。至于脑机接口这种热点，想参与也得先搞明白逻辑，别当最后接盘的那位。 行啦，今天的收评就聊到这儿。市场每天都有新故事，咱慢慢捋逻辑、看本质，中长线的钱得赚明白钱。记得关注帮主，每天收盘后咱一起拆解市场密码。 咱先说说今天最亮眼的崽——脑机接口概念。这板块今天简直是"开机即巅峰"，爱朋医疗、南京熊猫、创新医疗这些票直接涨停封板，荣泰健康也跟着冲上 涨停板。好多朋友可能纳闷，这脑机接口咋突然就火了？其实啊，最近圈里都在聊政策面的支持，还有些技术突破 ...

Market Overview - The main indices showed slight declines today, with the Shanghai Composite Index down by 0.04%, the Shenzhen Component down by 0.12%, and the ChiNext Index down by 0.36% [1] - In terms of industry performance, coal, public utilities, and oil & petrochemicals led the gains, while textiles, light manufacturing, and automotive sectors lagged behind [1] - Concept sectors showed varied performance, with continuous boards, digital currency, and high transfer concepts performing relatively well, while CRO, innovative drugs, and internet celebrity economy concepts underperformed [1]

机构观点 巨丰投顾：周二市场震荡运行，脑机接口板块涨幅居前。陆家嘴论坛召开在即，政策利好预期将推动A 股市场进一步上行。短线可关注数字货币等题材，中线建议持续关注大消费、半导体、机器人等受益于 政策支撑的行业。 富荣基金：过往经验表明，中东地缘政治通常会通过影响大宗商品价格和通胀预期，间接对国内资本市 场产生作用，对市场偏短期的情绪造成压制。但从中期股价的历史复盘情况来看，中东地缘政治较少成 为影响A股方向性变化的关键因素，建议关注后续局势的发展动向。短期内上证指数已接近震荡区间的 上沿，市场的内在稳定性较弱，对利空消息会更为敏感。中期看好具备产业景气逻辑的新兴成长方向， 如AI、半导体、机器人等领域。行业重点关注：成长赛道，如AI应用、半导体、医药等板块；底部区 间有拐点预期的板块，如证券、电新、消费等。 新华财经北京6月17日电 （王媛媛）周二A股三大指数小幅下跌。截至收盘，沪指报3387.40点，跌 0.04%，成交4580亿元；深证成指报10151.43点，跌0.12%，成交7492亿元；创业板指报2049.94点，跌 0.36%，成交3730亿元。 板块方面，脑机接口、油气、电池、核污染防治等板块涨 ...

以下是2025年6月17日的财经热点整理： --- 1. 美股高开高走 - 纳指涨1.52%，标普500涨0.94%，道指涨0.75%。费城半导体指数涨超3%，创2月下旬以来新高，AMD、Meta等科技股领涨。 - 纳斯达克中国金龙指数涨2.07%，富途控股涨超10%，脑再生科技暴涨近300%。 - 国际金价、油价分别下跌1.4%和2.06%，市场对中东局势缓和预期升温。 2. 港股与A股表现 - 港股恒指重返24000点，科技、金融板块领涨，高盛看好腾讯、阿里等"中国十巨头"标的。 - A股三大指数缩量反弹，稳定币、数字货币、AI眼镜概念活跃，但创新药板块冲高回落。 - 房地产：70城房价同比降幅继续收窄，但环比仍下降；杭州新房价格涨幅全国第一，无锡二手房价涨幅居首。 - 消费：5月社会消费品零售总额同比增长6.4%，以旧换新政策显效。 2. 金融政策 - 四大行定增：交通银行、中国银行完成超2850亿元定增，财政部5000亿元注资落地过半，预计释放约4.8万亿元信贷增量。 - AI与半导体：台积电、英伟达等科技巨头股价走强，AI数字人直播单场GMV破5500万元。 - 核医疗：广东计划到2030年培育3- ...

Market Overview - The Shanghai and Shenzhen stock markets opened mixed on June 17, with the Shanghai Composite Index slightly down and the Shenzhen Component and ChiNext Index slightly up [1] - By midday, the Shanghai Composite Index was at 3382.14 points, down 0.19%, with a trading volume of approximately 284.6 billion yuan; the Shenzhen Component was at 10163.07 points, down 0.00%, with a trading volume of about 486.9 billion yuan; the ChiNext Index was at 2054.48 points, down 0.14%, with a trading volume of around 244.3 billion yuan [1] Sector Performance - The brain engineering sector opened significantly higher but saw its gains narrow after an initial surge [1] - The oil and gas sector opened lower but rebounded significantly after two dips during the morning session [1] - Other sectors such as digital currency, AI glasses, solid-state batteries, wireless earphones, and lithium mining showed notable increases during the morning [1] - Conversely, sectors like weight loss drugs, short drama games, and disperse dyes experienced the largest declines [1] Institutional Insights - CITIC Securities predicts a clear trend of performance and valuation recovery in the healthcare industry by the second half of 2025, emphasizing innovation-driven and internationalization strategies [2] - Huatai Securities highlights increased risks in the Strait of Hormuz, which may disrupt global shipping supply chains, potentially leading to a new round of price increases in the shipping sector [2] - China Galaxy Securities notes that coal supply may decrease in June due to safety production measures, with domestic coal prices stabilizing and potentially rising due to improved supply-demand dynamics [2] Event Announcements - The China Council for the Promotion of International Trade announced that companies like Yushu Technology, Qiang Brain Technology, and NVIDIA will participate in the third Chain Expo from July 16 to 20 in Beijing, with over 100 new product launches expected [3] Government Initiatives - Beijing's Commerce Bureau announced subsidies for four types of smart home products, providing up to 2000 yuan per item for consumers purchasing smart toilets, smart locks, robotic vacuum cleaners, and garbage disposers [4]

Group 1: Brain-Computer Interface (BCI) Sector - The BCI sector is experiencing a surge due to supportive policies, with Hubei Medical Insurance Bureau setting service pricing and the National Medical Products Administration working on industry standards, pushing the sector into a "fast lane" [3] - Companies like Tencent have secured motion control patents, and Beijing Brain Science Institute has completed three human implant trials, indicating that technology is moving towards practical application [3] - Focus should be on companies with medical device licenses and R&D investment exceeding 20%, as they represent the "hardcore players" worth monitoring [3] Group 2: Digital Currency Sector - Companies like Lakala and Sifang Jingchuang have seen significant stock price increases, with Lakala's cross-border transaction volume up 85% year-on-year, covering over 100 countries [3] - Sifang Jingchuang is involved in multiple central bank digital currency interconnectivity projects, indicating a deepening phase of digital currency applications [3] - Caution is advised regarding companies that are merely riding the digital currency wave without solid fundamentals, as they may be "hollow" [3] Group 3: Solid-State Battery Sector - Companies such as Winbond Technology and Keli Yuan have seen stock price increases, driven by rising demand for high-energy-density batteries in low-altitude economies [4] - Collaboration between CATL and Fengfei Aviation on aviation-grade solid-state batteries has received aviation certification, with mass production expected by 2026 [4] - The Ministry of Industry and Information Technology has prioritized the development of solid-state battery standards, suggesting a long-term growth trajectory for this sector [4] Group 4: Weight Loss Drug Sector - The weight loss drug sector has faced challenges, with companies like Kexing Pharmaceutical seeing stock declines over 10%, primarily due to disappointing clinical trial results from overseas competitors [4] - Novo Nordisk's next-generation weight loss drug trial results were below expectations, leading to a significant market cap loss of nearly €90 billion, impacting domestic suppliers like Jinkai Biotechnology [4] - Despite current setbacks, the demand for obesity treatment remains, and companies with core technologies in CDMO may find opportunities post-emotional market correction [4] Group 5: IP Economy Sector - The IP economy sector has seen declines, with stocks like Hars and Baixinglong dropping over 5%, attributed to industry adjustments [5] - Nanjing Xinbai's attempt to leverage national trend IPs has not translated into increased foot traffic, which fell by 14.8% [5] - The market's expectations for the IP economy have shifted, necessitating tangible performance rather than mere concepts, highlighting the importance of companies that can convert IP into cash flow [5] Group 6: Market Indices - The recent adjustment in the Shanghai Composite Index is viewed positively, providing an opportunity to observe capital movements [6] - The North Stock 50 index rose by 34.57%, indicating that funds are seeking structural opportunities [6] - Long-term investment opportunities are evident in sectors like BCI, digital currency, and solid-state batteries, but investors should focus on companies with clinical progress, leading positions in cross-border payments, and technological advancements [6]

Core Viewpoint - The article emphasizes the importance of real-time information analysis in the investment landscape, particularly focusing on the digital currency and cross-border payment sectors, highlighting the role of digital RMB in enhancing payment systems and market presence [1] Group 1: Digital Currency and Cross-Border Payment - The company is actively involved in building the digital RMB CIPS system, which is crucial for facilitating cross-border payments [1] - The digital RMB hardware wallet has been successfully implemented, indicating progress in the adoption of digital currency [1] - The company holds a significant global market share in payment devices, with over 80% of its sales coming from overseas markets [1] Group 2: Partnerships and Collaborations - The company collaborates with various small and micro-financial enterprises, including notable partners like Ant Bank and JD Technology, to enhance its service offerings [1]

Market Overview - The three major A-share indices experienced collective adjustments, with the Shanghai Composite Index down by 0.19%, the Shenzhen Component Index flat, and the ChiNext Index down by 0.14% [1] - The total market turnover for the half-day session was 790.2 billion yuan, a decrease of 15.3 billion yuan compared to the previous day [1] - Over 3,000 stocks in the market were in the red [1] Sector Performance - The brain-computer interface, oil and gas, digital currency, and solid-state battery sectors saw the highest gains [2] - The brain-computer interface concept led the gains, with stocks like Aipeng Medical, Nanjing Panda, Innovation Medical, and Rongtai Health hitting the daily limit [2] - The digital currency sector remained active, with stocks such as Chuangshi Technology and Hengbao shares also hitting the daily limit, while Lakala and Sifang Jingchuang rose over 10% [2] - The solid-state battery sector also performed well, with Yinghe Technology and Keli Yuan reaching the daily limit [2] - The weight loss drug sector led the declines, with Kexing Pharmaceutical dropping over 10% [2] - The IP economy concept stocks collectively adjusted, with several stocks like Hars and Bai Xinglong falling over 5% [2] Notable Stocks and Trends - The top gainers included companies like Xiexin Energy Technology and Zhun Oil, which achieved three consecutive limit-ups [4] - Companies such as Beida Pharmaceutical and Hengbao shares recorded two consecutive limit-ups [5] - The e-commerce sector had nine stocks hitting the daily limit, with Shandong Molong and Zhujiang Piano being notable representatives [6] - The robotics concept saw seven stocks hitting the daily limit, with Gaole shares and Rongtai Health being key players [7] - The Huawei concept also had six stocks hitting the daily limit, including Xiexin Energy Technology and Hengbao shares [8] Innovation Drug Sector - The National Medical Products Administration plans to clarify the category of drugs that will be included in the 30-day review and approval channel for clinical trials of innovative drugs, aiming to support the development of innovative drugs based on clinical value [9] Digital Currency Sector - Circle's stock in the US saw a significant increase, rising nearly 21% and reaching a historical high, with a cumulative increase of over 420% since its listing [10] Brain-Computer Interface Sector - The first brain-computer interface outpatient clinic in Central China has been established, providing technical evaluation and treatment consultation for patients, which may be included in clinical trial queues for cutting-edge treatments [11] - The brain-computer interface industry is expected to grow rapidly, with McKinsey predicting a market size of $40 billion in the medical field by 2030 and potentially exceeding $145 billion by 2040 [12]

Market Overview - The three major stock indices experienced fluctuations and rose, with the North China 50 Index increasing by nearly 2% [1] - As of the close, the Shanghai Composite Index rose by 0.35% to 3388.73 points, the Shenzhen Component Index increased by 0.41% to 10163.55 points, and the ChiNext Index rose by 0.66% to 2057.32 points [1] - The total trading volume in the Shanghai, Shenzhen, and North markets was 12,438 billion yuan, a decrease of approximately 2,600 billion yuan compared to the previous day [1] Sector Performance - Strong performance was observed in sectors such as media, real estate, oil, brokerage, banking, and insurance [1] - Coal, chemical, and liquor sectors also saw upward movement, while digital currency, information technology innovation, and AI application concepts were active [1] Investment Insights - Dongxing Securities indicated that under current volume conditions, the likelihood of a style switch in the market is low, with small and mid-cap growth styles expected to continue [1] - There may be a small cycle adjustment in the short term due to high congestion in small-cap stocks, but the possibility of a large cycle adjustment is low [1] - The A-share market is expected to enter a slow bull phase, with large-cap companies likely to follow small-cap companies into an upward trend [1] Focus Areas - The market continues to favor mainstream hotspots such as innovative drugs and new consumption, while also looking for opportunities in undervalued high-dividend stocks [1] - In the context of continuously declining interest rates, high-dividend stocks are considered a scarce resource with long-term allocation value [1] Oil and Gas Sector - The outbreak of the Israel-Palestine conflict on June 13 led to a 7% increase in Brent crude oil prices, with prices stabilizing between $70 and $75 per barrel as of June 16 [2] - The conflict may alter the global oil supply landscape, suggesting a systematic upward shift in oil price levels [2] - Dongwu Securities noted that the current extraction costs in major U.S. shale oil regions are between $40 and $50 per barrel, indicating that rising oil prices will enhance shale oil extraction willingness [2] Pharmaceutical Sector - The State Council's meeting on June 13 focused on optimizing drug and consumable procurement policies, aiming to enhance the innovation capabilities of pharmaceutical companies [3][4] - Policies are expected to encourage the development of innovative drugs and medical devices, potentially benefiting leading companies in the sector [4] - The optimization of procurement policies is anticipated to restore market sentiment and catalyze the pharmaceutical sector's growth in the second half of the year [4] Regulatory Developments - The National Medical Products Administration announced a 30-day review and approval process for clinical trial applications of innovative drugs, aimed at enhancing the efficiency of clinical research [5] - This initiative supports the development of key national research products and encourages international collaboration in clinical trials [5]

投资咨询业务资格：证监许可【2012】669号 中信期货研究|⾦融衍⽣品策略⽇报 2025-06-17 股市缺乏主线，债市曲线⾛陡 股指期货：地缘冲击淡化，等待陆家嘴论坛政策。 股指期权：波动快速触底，买权为主。 国债期货：债市曲线⾛陡。 股指期货方面，地缘冲击淡化，等待陆家嘴论坛政策。周一继续缺少 主线方向。地缘事件的影响相对淡化，伊朗主要领导层被定向击杀，妥协 只是时间问题，预期差有限，黄金、原油价格均高位回落。市场关注转向 本周的陆家嘴论坛，传涉及数字货币、科技与产业与金融良性循环等， 催化稳定币等主题概念活跃，资金提前布局，TMT板块领涨。然而经济弱 现实仍未改变，PPI同比负增扩大，国补外的社零增速平缓，关注陆家嘴 论坛是否有改善产业利润分配的实质性政策表态。另外，港股隐忧继续提 示资金拥挤风险，恒生AH溢价指数创五年来新低，部分公司出现H股溢 价，而近年AH溢价低位多对应于沪深300高位，存在港股连累A股的可能 性，操作偏向防御。 股指期权方面，波动快速触底，买权为主。昨日，波动率骤降，50ET F期权加权水平来到13.2%，而当月平值在12%左右，而中证1000股指期权 来到近250个交易日最小 ...